These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

222 related items for PubMed ID: 27418543

  • 1. Icosapent ethyl: Eicosapentaenoic acid concentration and triglyceride-lowering effects across clinical studies.
    Bays HE, Ballantyne CM, Doyle RT, Juliano RA, Philip S.
    Prostaglandins Other Lipid Mediat; 2016 Sep; 125():57-64. PubMed ID: 27418543
    [Abstract] [Full Text] [Related]

  • 2. Icosapent ethyl (eicosapentaenoic acid ethyl ester): Effects on remnant-like particle cholesterol from the MARINE and ANCHOR studies.
    Ballantyne CM, Bays HE, Philip S, Doyle RT, Braeckman RA, Stirtan WG, Soni PN, Juliano RA.
    Atherosclerosis; 2016 Oct; 253():81-87. PubMed ID: 27596132
    [Abstract] [Full Text] [Related]

  • 3. Icosapent ethyl, a pure EPA omega-3 fatty acid: effects on plasma and red blood cell fatty acids in patients with very high triglyceride levels (results from the MARINE study).
    Braeckman RA, Manku MS, Bays HE, Stirtan WG, Soni PN.
    Prostaglandins Leukot Essent Fatty Acids; 2013 Sep; 89(4):195-201. PubMed ID: 23992935
    [Abstract] [Full Text] [Related]

  • 4. Icosapent ethyl (eicosapentaenoic acid ethyl ester): Effects on plasma apolipoprotein C-III levels in patients from the MARINE and ANCHOR studies.
    Ballantyne CM, Bays HE, Braeckman RA, Philip S, Stirtan WG, Doyle RT, Soni PN, Juliano RA.
    J Clin Lipidol; 2016 Sep; 10(3):635-645.e1. PubMed ID: 27206952
    [Abstract] [Full Text] [Related]

  • 5. Usefulness of Icosapent Ethyl (Eicosapentaenoic Acid Ethyl Ester) in Women to Lower Triglyceride Levels (Results from the MARINE and ANCHOR Trials).
    Mosca L, Ballantyne CM, Bays HE, Guyton JR, Philip S, Doyle RT, Juliano RA.
    Am J Cardiol; 2017 Feb 01; 119(3):397-403. PubMed ID: 27939227
    [Abstract] [Full Text] [Related]

  • 6. Lipid Effects of Icosapent Ethyl in Women with Diabetes Mellitus and Persistent High Triglycerides on Statin Treatment: ANCHOR Trial Subanalysis.
    Brinton EA, Ballantyne CM, Guyton JR, Philip S, Doyle RT, Juliano RA, Mosca L.
    J Womens Health (Larchmt); 2018 Sep 01; 27(9):1170-1176. PubMed ID: 29583081
    [Abstract] [Full Text] [Related]

  • 7. Icosapent ethyl for treatment of elevated triglyceride levels.
    Nelson SD, Munger MA.
    Ann Pharmacother; 2013 Nov 01; 47(11):1517-23. PubMed ID: 24259598
    [Abstract] [Full Text] [Related]

  • 8. Icosapent ethyl: a review of its use in severe hypertriglyceridemia.
    Kim ES, McCormack PL.
    Am J Cardiovasc Drugs; 2014 Dec 01; 14(6):471-8. PubMed ID: 25428605
    [Abstract] [Full Text] [Related]

  • 9. Effects of Icosapent Ethyl (Eicosapentaenoic Acid Ethyl Ester) on Atherogenic Lipid/Lipoprotein, Apolipoprotein, and Inflammatory Parameters in Patients With Elevated High-Sensitivity C-Reactive Protein (from the ANCHOR Study).
    Miller M, Ballantyne CM, Bays HE, Granowitz C, Doyle RT, Juliano RA, Philip S.
    Am J Cardiol; 2019 Sep 01; 124(5):696-701. PubMed ID: 31277790
    [Abstract] [Full Text] [Related]

  • 10. Icosapent ethyl, a pure EPA omega-3 fatty acid: effects on lipoprotein particle concentration and size in patients with very high triglyceride levels (the MARINE study).
    Bays HE, Braeckman RA, Ballantyne CM, Kastelein JJ, Otvos JD, Stirtan WG, Soni PN.
    J Clin Lipidol; 2012 Sep 01; 6(6):565-72. PubMed ID: 23312052
    [Abstract] [Full Text] [Related]

  • 11. Effects of switching from omega-3-acid ethyl esters to icosapent ethyl in a statin-treated patient with elevated triglycerides.
    Kedia AW, Lynch E.
    Postgrad Med; 2015 Sep 01; 127(8):869-73. PubMed ID: 26453247
    [Abstract] [Full Text] [Related]

  • 12. Effect of Vascepa (icosapent ethyl) on progression of coronary atherosclerosis in patients with elevated triglycerides (200-499 mg/dL) on statin therapy: Rationale and design of the EVAPORATE study.
    Budoff M, Brent Muhlestein J, Le VT, May HT, Roy S, Nelson JR.
    Clin Cardiol; 2018 Jan 01; 41(1):13-19. PubMed ID: 29365351
    [Abstract] [Full Text] [Related]

  • 13. Icosapent ethyl for the treatment of hypertriglyceridemia.
    Ballantyne CM, Braeckman RA, Soni PN.
    Expert Opin Pharmacother; 2013 Jul 01; 14(10):1409-16. PubMed ID: 23701295
    [Abstract] [Full Text] [Related]

  • 14. Reducing residual cardiovascular risk in Europe: Therapeutic implications of European medicines agency approval of icosapent ethyl/eicosapentaenoic acid.
    Chapman MJ, Zamorano JL, Parhofer KG.
    Pharmacol Ther; 2022 Sep 01; 237():108172. PubMed ID: 35304222
    [Abstract] [Full Text] [Related]

  • 15. Icosapent Ethyl Effects on Fatty Acid Profiles in Statin-Treated Patients With High Triglycerides: The Randomized, Placebo-controlled ANCHOR Study.
    Ballantyne CM, Manku MS, Bays HE, Philip S, Granowitz C, Doyle RT, Juliano RA.
    Cardiol Ther; 2019 Jun 01; 8(1):79-90. PubMed ID: 30788718
    [Abstract] [Full Text] [Related]

  • 16. Icosapent ethyl reduces atherogenic markers in high-risk statin-treated patients with stage 3 chronic kidney disease and high triglycerides.
    Vijayaraghavan K, Szerlip HM, Ballantyne CM, Bays HE, Philip S, Doyle RT, Juliano RA, Granowitz C.
    Postgrad Med; 2019 Aug 01; 131(6):390-396. PubMed ID: 31306043
    [Abstract] [Full Text] [Related]

  • 17. Effects of icosapent ethyl on lipoprotein particle concentration and size in statin-treated patients with persistent high triglycerides (the ANCHOR Study).
    Ballantyne CM, Braeckman RA, Bays HE, Kastelein JJ, Otvos JD, Stirtan WG, Doyle RT, Soni PN, Juliano RA.
    J Clin Lipidol; 2015 Aug 01; 9(3):377-83. PubMed ID: 26073397
    [Abstract] [Full Text] [Related]

  • 18. Icosapent ethyl, a pure ethyl ester of eicosapentaenoic acid: effects on circulating markers of inflammation from the MARINE and ANCHOR studies.
    Bays HE, Ballantyne CM, Braeckman RA, Stirtan WG, Soni PN.
    Am J Cardiovasc Drugs; 2013 Feb 01; 13(1):37-46. PubMed ID: 23325450
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Translating plasma eicosapentaenoic acid concentrations into erythrocyte percentages of eicosapentaenoic acid plus docosahexaenoic acid during treatment with icosapent ethyl.
    Harris WS, Jackson KH.
    J Clin Lipidol; 2019 Feb 01; 13(5):771-777. PubMed ID: 31401072
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.